Rupatadin Fumarate 25mg | ≥99%
CSNpharm
Rupatadine fumarate is an inhibitor of PAFR and histamine (H1) receptor with Ki of 550 nM and 102 nM, respectively.
More Information Supplier PageRupatadin Fumarate
Search Results
Rupatadin Fumarate 100mg | ≥99%
CSNpharm
Rupatadine fumarate is an inhibitor of PAFR and histamine (H1) receptor with Ki of 550 nM and 102 nM, respectively.
More Information Supplier PageRupatadin Fumarate
Dehydrocostus Lactone 10mg | ≥98%
CSNpharm
Dehydrocostus Lactone a naturally occuring sesquiterpene lactone in the roots of Saussurea lappa with anti-inflammatory activity.
More Information Supplier PageDehydrocostus Lactone
Dehydrocostus Lactone 5mg | ≥98%
CSNpharm
Dehydrocostus Lactone a naturally occuring sesquiterpene lactone in the roots of Saussurea lappa with anti-inflammatory activity.
More Information Supplier PageDehydrocostus Lactone
BSI-201 250mg | ≥97%
CSNpharm
BSI-201 is a PARP1 inhibitor with demonstrated effectiveness in triple-negative breast cancer (TNBC).
More Information Supplier PageBSI-201
BSI-201 5mg | ≥97%
CSNpharm
BSI-201 is a PARP1 inhibitor with demonstrated effectiveness in triple-negative breast cancer (TNBC).
More Information Supplier PageBSI-201
BSI-201 50mg | ≥97%
CSNpharm
BSI-201 is a PARP1 inhibitor with demonstrated effectiveness in triple-negative breast cancer (TNBC).
More Information Supplier PageBSI-201
BSI-201 10mg | ≥97%
CSNpharm
BSI-201 is a PARP1 inhibitor with demonstrated effectiveness in triple-negative breast cancer (TNBC).
More Information Supplier PageBSI-201
BSI-201 25mg | ≥97%
CSNpharm
BSI-201 is a PARP1 inhibitor with demonstrated effectiveness in triple-negative breast cancer (TNBC).
More Information Supplier PageBSI-201
BSI-201 100mg | ≥97%
CSNpharm
BSI-201 is a PARP1 inhibitor with demonstrated effectiveness in triple-negative breast cancer (TNBC).
More Information Supplier PageBSI-201